Algert Global’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-8,723
Closed -$1.09M 574
2020
Q4
$1.09M Sell
8,723
-1,279
-13% -$143K 0.31% 117
2020
Q3
$1.01M Hold
10,002
0.32% 123
2020
Q2
$973K Sell
10,002
-3,123
-24% -$291K 0.33% 109
2020
Q1
$1.09M Buy
13,125
+5,109
+64% +$498K 0.46% 63
2019
Q4
$891K Buy
+8,016
New +$825K 0.27% 135
2017
Q4
Sell
-25,412
Closed -$1.94M 369
2017
Q3
$1.94M Sell
25,412
-4,432
-15% -$335K 0.44% 101
2017
Q2
$2.24M Sell
29,844
-10,134
-25% -$703K 0.63% 44
2017
Q1
$2.61M Buy
39,978
+30,051
+303% +$1.77M 0.7% 16
2016
Q4
$547K Buy
+9,927
New +$545K 0.16% 223

Other funds holding PRAH

Algert Global's PRAH Position: Q1 2021 in Review

Algert Global sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 8,723 shares — an estimated $1.09M sold.

Algert Global first reported a position in PRAH in Q4 2016 and held it in 9 quarters. The position peaked at $2.61M in Q1 2017. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Algert Global reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Algert Global sold 8,723 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $1.09M.
  • Algert Global first reported a position in PRA Health Sciences, Inc. in Q4 2016 and held it in 9 quarters.
  • Algert Global's PRA Health Sciences, Inc. position peaked at $2.61M in Q1 2017.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Algert Global's 13F filing for Q1 2021, filed 14 May 2021.